Helix Biopharma Corp. Announces Board Composition Changes
来源：TheNewswire发布于 2026-08-14
Vancouver, British Columbia; August 14, 2026 – TheNewswire - Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0”) ( “Helix” or the “Company”), a clinical-stage oncology company...
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。